Clinical review report Dapagliflozin (Forxiga)
The objective of this report is to perform a systematic review of the beneficial and harmful effects of dapagliflozin 5 mg and 10 mg tablets for the treatment of heart failure with reduced ejection fraction in adults.
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Ottawa, Ontario :
Canadian Agency for Drugs and Technologies in Health
2016.
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820283306719 |
| Sumario: | The objective of this report is to perform a systematic review of the beneficial and harmful effects of dapagliflozin 5 mg and 10 mg tablets for the treatment of heart failure with reduced ejection fraction in adults. |
|---|---|
| Descripción Física: | 1 online resource (1 PDF file (81 pages)) : illustrations |
